A cross-sectional multicoated study designed to determine the major extent and management of drug-related mental health problems in Europe. It will examine the prevalence and pattern of drug using population of hospitalised patients with acute psychosis; identify the role of cannabis and other drug use; the aetiology of acute psychotic illness and in the genesis of chronic psychosis; determine whether or not a clear syndrome of acute psychosis is associated with cannabis use exists; cost analysis of treatment given to patients with drug and mental health problems (co-morbidity) and determine the universality of this syndrome. The role of cannabis and other illicit substances in precipitate ting relapse in pre-existing psychotic illness will also be evaluated. The study will also examine in each centre the nature of treatment, type of services for co-morbidity clients and role of national/regional policies on treatment provision.
Funding SchemeCSC - Cost-sharing contracts